Virginia Carreira
Primary Care · Long Branch, NJNPI 1801970868
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,769 of the $5,758 with a category attached, or 65.4%. 23 manufacturers reported payments, led by Insulet Corporation at 29.3% of the total. Reporting peaked in 2022 at $2,496 and has fallen 55.9% since, to $1,101 in 2025. Among primary care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $78.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$2K
- Medtronic$916
- AstraZeneca$807
- Otsuka America Pharmaceutical, Inc.$221
- Abbott$190
- Boehringer Ingelheim$181
- plus $2K from 17 others
What the payments were for
- Speaking & faculty fees$1,80131%
- Travel & lodging$892%
- Food & beverage$3,76965%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 8 | $1,689 |
| Medtronic | 26 | $916 |
| AstraZeneca(2 entities) | 8 | $807 |
| Otsuka America Pharmaceutical, Inc. | 2 | $221 |
| Abbott | 3 | $190 |
| Boehringer Ingelheim | 2 | $181 |
| Abiomed | 8 | $176 |
| Sanofi | 1 | $146 |
| Janssen Scientific Affairs, LLC | 1 | $143 |
| Boston Scientific | 1 | $140 |
| SK Life Science, Inc. | 1 | $124 |
| Urovant Sciences Inc | 1 | $119 |
| Lilly USA, LLC | 1 | $112 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $104 |
| Novo Nordisk | 1 | $99 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Novocure Inc. | 1 | $97 |
| Sanofi Pasteur Inc. | 1 | $95 |
| Coloplast | 1 | $88 |
| Silk Road Medical, Inc. | 1 | $88 |
| Johnson & Johnson | 1 | $66 |
| Pfizer | 1 | $40 |
| Shockwave Medical, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$1,600
- MINIMED 770G$201
- SYMPLICITY G3$163
- DUPIXENT$146
- SPRAVATO$143
- WATCHMAN FLX$140
- ANDEXXA$125
- WAINUA$125
- BREZTRI$125
- REXULTI$125
- XCOPRI$124
- GEMTESA$119
- KISUNLA$112
- XIFAXAN$104
How this compares
$5,758 in reported general payments places this provider in the 95th percentile of 330 primary care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 72 | $386 |
| Potassium Chloride | 30 | $205 |
Paid to pharmacies, not to this prescriber.
Other primary care in Long Branch
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
- Anna NievesBasking Ridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.